Haleon PLC (GB:HLN) has released an update.
Haleon PLC, a global leader in consumer health, announced the repurchase of 293,991 of its own shares on September 4, 2024, as part of a share buyback program initiated earlier on August 1. The share buyback, involving shares valued between 381.5 pence and 386 pence each, leads to a reduction in the company’s registered share capital. Haleon is known for well-established brands such as Advil, Sensodyne, and Centrum, and emphasizes its commitment to improving everyday health.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.
